US2015329503A1PendingUtilityA1

Substituted benzamides and their uses

Assignee: UNIV LELAND STANFORD JUNIORPriority: Oct 11, 2010Filed: Jul 20, 2015Published: Nov 19, 2015
Est. expiryOct 11, 2030(~4.2 yrs left)· nominal 20-yr term from priority
A61P 35/00C07D 409/12C07D 413/12C07D 405/12C07D 413/14C07D 417/12C07D 213/75A61P 27/02C07D 401/12C07D 263/32A61K 31/422A61K 31/4427
37
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Provided herein are Substituted Benzamides, compositions, and method of their manufacture and use.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A compound of Formula I: 
       
         
           
           
               
               
           
         
         or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, enantiomer or stereoisomer thereof, 
         wherein:
 A is a nitrogen-containing heteroaryl ring chosen from pyridinyl, pyrazinyl, and imidazolyl, each of which is optionally substituted; 
 X is CH 2 CH 2 NR, CH 2 NR, or NR wherein each R is independently chosen from hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heterocycloalkyl, and heteroaryl, each of which, except for hydrogen, is optionally substituted; 
 R 1 , R 2 , R 3 , and R 4  are each independently chosen from hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heterocycloalkyl, and heteroaryl, each of which, except for hydrogen, is optionally substituted; 
 Y is chosen from O, S, NR; wherein each R is independently chosen from hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heterocycloalkyl, and heteroaryl, each of which, except for hydrogen, is optionally substituted; 
 B is an optionally substituted aryl ring; 
 
         provided that if A is 3-pyridinyl, X is CH 2 NH, R 1 , R 2 , and R 4  are each hydrogen, R 3  is methyl, and Y is O, then B is not phenyl or 4-methylphenyl. 
       
     
     
         2 . The compound of  claim 1 , wherein A is chosen from 2-pyrazinyl, 2-pyridinyl, 3-pyridinyl, 4-pyridinyl, 2-imidazolyl, and 5-imidazolyl, each of which is optionally substituted. 
     
     
         3 . The compound of  claim 1 , wherein A is chosen from 2-pyrazinyl, 2-pyridinyl, 3-pyridinyl, 4-pyridinyl, (1-methyl)-2-imidazolyl, and (1-methyl)-5-imidazolyl. 
     
     
         4 . The compound of  claim 1 , wherein A is chosen from 2-pyridinyl, 3-pyridinyl, and 4-pyridinyl. 
     
     
         5 . The compound of  claim 1 , wherein A is 3-pyridinyl. 
     
     
         6 . The compound of  claim 1 , wherein R1 is chosen from hydrogen and optionally substituted alkyl. 
     
     
         7 . The compound of  claim 1 , wherein R1 is chosen from hydrogen and lower alkyl. 
     
     
         8 . The compound of  claim 1 , wherein R1 is hydrogen or methyl. 
     
     
         9 . The compound of  claim 1 , R1 is hydrogen. 
     
     
         10 . The compound of  claim 1 , wherein R2, R3 and R4 are each independently chosen from hydrogen and optionally substituted alkyl. 
     
     
         11 . The compound of  claim 1 , wherein R 2  is hydrogen. 
     
     
         12 . The compound of  claim 1 , wherein R 3  is chosen from hydrogen and lower alkyl. 
     
     
         13 . The compound of  claim 1 , wherein R 3  is hydrogen or methyl. 
     
     
         14 . The compound of  claim 1 , wherein R 4  is chosen from hydrogen and lower alkyl. 
     
     
         15 . The compound of  claim 1 , wherein R 4  is hydrogen. 
     
     
         16 . The compound of  claim 1 , wherein X is chosen from CH 2 CH 2 NR, CH 2 NR, or NR. 
     
     
         17 . The compound of  claim 1 , wherein R is chosen from hydrogen and lower alkyl. 
     
     
         18 . The compound of  claim 1 , wherein R is hydrogen. 
     
     
         19 . The compound of  claim 1 , wherein Y is chosen from O, S, or NR. 
     
     
         20 . The compound of  claim 1 , wherein R is chosen from hydrogen and lower alkyl. 
     
     
         21 . The compound of  claim 1 , wherein R is hydrogen. 
     
     
         22 . The compound of  claim 1 , wherein R is O. 
     
     
         23 . The compound of  claim 1 , wherein R is S. 
     
     
         24 . The compound of  claim 1 , wherein B is phenyl optionally substituted with one or more groups chosen from halo, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heteroaryl, heterocycloalkyl, hydroxyl, alkoxy, aryloxy, acyl, carboxy, alkoxycarbonyl, NO 2 , optionally substituted amino, and CN, wherein each of said alkyl, alkenyl, alkynyl, alkoxy, cycloalkyl, aryl, heteroaryl, heterocycloalkyl, alkoxy, and aryloxy groups may be optionally independently substituted with one or more groups chosen from halo, alkyl, hydroxyl, alkoxy, carboxy, alkoxycarbonyl, heterocycloalkyl, and optionally substituted amino. 
     
     
         25 . The compound of  claim 1 , wherein B is phenyl optionally substituted with one or more groups chosen from optionally substituted amino, halo, and lower alkyl optionally substituted with optionally substituted amino, heterocycloalkyl, alkoxy, or hydroxyl. 
     
     
         26 . The compound of  claim 1 , wherein B is phenyl optionally substituted with one or more groups chosen from halo, optionally substituted amino and lower alkyl optionally substituted with optionally substituted amino or heterocycloalkyl. 
     
     
         27 . The compound of  claim 1 , wherein B is chosen from phenyl, 3-methylphenyl, 3-methoxyphenyl, 4-chlorophenyl, 4-tert-butylphenyl, 4-bromophenyl, 4-fluorophenyl, 4-methoxyphenyl, 4-(4-methylpiperazinyl)phenyl, 4-morpholinylphenyl, 3,5-dimethylphenyl, 2,4-dimethylphenyl, 3,4-dimethoxyphenyl. 
     
     
         28 . The compound of  claim 1  selected from the group consisting of:
 4-(5-Methyl-4-{[(4-methylphenyl)sulfonyl]methyl}-1,3-oxazol-2-yl)-N-(3-pyridinyl)benzamide; 
 4-(5-Methyl-4-{[(4-methylphenyl)sulfonyl]methyl}-1,3-oxazol-2-yl)-N-(4-pyridinyl)benzamide; 
 N-Methyl-4-(5-methyl-4-{[(4-methylphenyl)sulfonyl]methyl}-1,3-oxazol-2-yl)-N-(3-pyridinyl)benzamide; 
 4-(5-Methyl-4-{[(4-methylphenyl)sulfonyl]methyl}-1,3-oxazol-2-yl)-N-(2-pyridinylmethyl)benzamide; 
 4-(5-Methyl-4-{[(4-methylphenyl)sulfonyl]methyl}-1,3-oxazol-2-yl)-N-(3-pyridinylmethyl)benzamide; 
 4-(5-Methyl-4-{[(4-methylphenyl)sulfonyl]methyl}-1,3-oxazol-2-yl)-N-(4-pyridinylmethyl)benzamide; 
 N-Methyl-4-(5-methyl-4-{[(4-methylphenyl)sulfonyl]methyl}-1,3-oxazol-2-yl)-N-(3-pyridinylmethyl)benzamide; 
 4-(5-Methyl-4-{[(4-methylphenyl)sulfonyl]methyl}-1,3-oxazol-2-yl)-N-[2-(3-pyridinyl)ethyl]benzamide; 
 4-(5-Methyl-4-{[(4-methylphenyl)sulfonyl]methyl}-1,3-oxazol-2-yl)-N-(2-pyrazinylmethyl)benzamide; 
 N-[(1-Methyl-1H-imidazol-2-yl)methyl]-4-(5-methyl-4-{[(4-methylphenyl)sulfonyl]methyl}-1,3-oxazol-2-yl)benzamide; 
 N-[(1-Methyl-1H-imidazol-5-yl)methyl]-4-(5-methyl-4-{[(4-methylphenyl)sulfonyl]methyl}-1,3-oxazol-2-yl)benzamide; 
 4-{5-Methyl-4-[(phenylsulfonyl)methyl]-1,3-oxazol-2-yl}-N-(3-pyridinylmethyl)benzamide; 
 4-(4-{[(4-Chlorophenyl)sulfonyl]methyl}-5-methyl-1,3-oxazol-2-yl)-N-(3-pyridinylmethyl)benzamide; 
 4-(4-{[(4-tert-Butylphenyl)sulfonyl]methyl}-5-methyl-1,3-oxazol-2-yl)-N-(3-pyridinylmethyl)benzamide; 
 4-(4-{[(3,5-Dimethylphenyl)sulfonyl]methyl}-5-methyl-1,3-oxazol-2-yl)-N-(3-pyridinylmethyl)benzamide; 
 4-(4-{[(4-Bromophenyl)sulfonyl]methyl}-5-methyl-1,3-oxazol-2-yl)-N-(3-pyridinylmethyl)benzamide; 
 4-(5-Methyl-4-{[(3-methylphenyl)sulfonyl]methyl}-1,3-oxazol-2-yl)-N-(3-pyridinylmethyl)benzamide; 
 4-(4-{[(4-Methoxyphenyl)sulfonyl]methyl}-5-methyl-1,3-oxazol-2-yl)-N-(3-pyridinylmethyl)benzamide; 
 4-(5-Methyl-4-{[(3-methoxyphenyl)sulfonyl]methyl}-1,3-oxazol-2-yl)-N-(3-pyridinylmethyl)benzamide; 
 4-(4-{[(3,4-Dimethoxyphenyl)sulfonyl]methyl}-5-methyl-1,3-oxazol-2-yl)-N-(3-pyridinylmethyl)benzamide; 
 4-(5-Methyl-4-{[(2,4-dimethylphenyl)sulfonyl]methyl}-1,3-oxazol-2-yl)-N-(3-pyridinylmethyl)benzamide; 
 4-(4-{[(4-Fluorophenyl)sulfonyl]methyl}-5-methyl-1,3-oxazol-2-yl)-N-(3-pyridinylmethyl)benzamide; 
 4-[5-Methyl-4-({[4-(4-methyl-1-piperazinyl)phenyl]sulfonyl}methyl)-1,3-oxazol-2-yl]-N-(3-pyridinylmethyl)benzamide; 
 4-[5-Methyl-4-({[4-(4-morpholinyl)phenyl]sulfonyl}methyl)-1,3-oxazol-2-yl]-N-(3-pyridinylmethyl)benzamide; 
 4-(4-{[(4-Methylphenyl)sulfonyl]methyl}-1,3-thiazol-2-yl)-N-(3-pyridinylmethyl)benzamide; 
 or a pharmaceutically acceptable salt thereof.

Join the waitlist — get patent alerts

Track US2015329503A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.